• Username (E-mail)
  • Password
Dow 19,827 -0.3%  EStoxx50 3,285 -0.3%  Nikkei 18,814 -1.5%  EUR 1.0708 0.0% 
Nasdaq 5,539 -0.6%  FTSE100 7,220 -1.5%  Yen 112.7080 0.0%  Oil 55.5 -0.4% 
S&P500 2,268 -0.3%  DAX 11,540 -0.1%  GBP 1.2401 0.0%  Gold 1,216 0.0% 

Alexion Pharmaceuticals share [Symbol: ALXN / ISIN: US0153511094]

Realtimequote Alexion Pharmaceuticals Inc. in USD

Exchange Market
135.29
Last
109,624
Volume
Time 03:59 PM
01/17/2017 03:59:59 PM UTC-0500
activate push

Stock Price Alexion Pharmaceuticals Inc. in USD

Activate push
135.30 USD -1.63 USD -1.19 %
Trade Time 5:20 PM Trade Date 1/17/2017
Daily High 136.79 Open 136.19
Daily Low 134.57 Prev. Close 135.30
52-week High 163.56 Volume (Qty.) 587,274
52-week Low 109.13 Market Cap (USD) 30.51 B
52-week Perf.
Exchange

Analyst Opinions for Alexion Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
10/25/12
Alexion Pharmaceuticals UBS AG
07/27/12
Alexion Pharmaceuticals Stifel, Nicolaus & Co., Inc.
07/26/12
Alexion Pharmaceuticals UBS AG
04/26/12
Alexion Pharmaceuticals Jefferies & Company Inc.
02/23/12
Alexion Pharmaceuticals UBS AG

Moody's Rating for Alexion Pharmaceuticals Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Alexion Pharmaceuticals Inc.

Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Its products include soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in New Haven, CT.
pagehit

Add or Edit Instrument

Alexion Pharmaceuticals Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Alexion Pharmaceuticals

2015 2016e 2017e
Dividend - - -
Dividend Yield in % - - -
P/E Ratio 37.93 24.02 20.01
EPS 4.99 4.64 5.57

Alexion Pharmaceuticals Key Figures

Market Cap (USD) 30.51 B
Free Float in % 99.44
Number of Shares (Mio.) 223.93
Cash Flow per Share 0.93
Book Value per Share 23.34
60-Days Volatility 59.65
P/B Ratio 8.11

Base Data Alexion Pharmaceuticals

Symbol ALXN
ISIN US0153511094
Indices NASDAQ Comp., S&P 500, NASDAQ 100, BX Swiss - USA

About the Company Alexion Pharmaceuticals

Country USA

Alexion Pharmaceuticals Historical Prices

01/12/2017
01/12/2017 06:00:00 PM UTC-0500
136.93 498,179
01/11/2017
01/11/2017 06:00:00 PM UTC-0500
137.35 619,289
01/10/2017
01/10/2017 06:00:00 PM UTC-0500
136.66 1,318,920
01/09/2017
01/09/2017 06:00:00 PM UTC-0500
143.67 742,571
01/08/2017
01/08/2017 06:00:00 PM UTC-0500
144.77 773,208

Alexion Pharmaceuticals Peer Group

Abbott Laboratories 40.90
-0.1%
Alexion Pharmaceuticals 135.30
-1.2%
AstraZeneca 45.32
-0.9%
Bayer 100.70
-0.4%
GlaxoSmithKline 15.53
-1.8%
Johnson & Johnson 114.87
0.2%
Merck 61.48
-1.4%
Novartis 71.45
-1.0%
Pfizer 32.06
-1.4%
Roche 239.30
-0.3%

Similar shares with higher 1-year perf.